Ripretinib in Combination With Binimetinib in Patients With Gastrointestinal Stromal Tumor (GIST)

Condition:   Gastrointestinal Stromal Tumors Interventions:   Drug: Ripretinib;   Drug: binimetinib Sponsor:   Deciphera Pharmaceuticals LLC Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials